Anuj Aggarwal
Finanzdirektor/CFO bei EVERSPIN TECHNOLOGIES, INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Anuj Aggarwal
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EVERSPIN TECHNOLOGIES, INC. | Comptroller/Controller/Auditor | 01.06.2021 | - |
Finanzdirektor/CFO | 30.04.2021 | - | |
Corporate Officer/Principal | 01.10.2020 | 30.04.2021 |
Karriereverlauf von Anuj Aggarwal
Ehemalige bekannte Positionen von Anuj Aggarwal
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Patheon Pharmaceuticals, Inc.
Patheon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Patheon, Inc., Patheon Pharmaceuticals, Inc. is a trusted end-to-end contract development and manufacturing organization partner for the pharmaceutical, biotech, and life sciences industries. The company is based in Durham, NC. Benefit from a single vendor along your entire development journey by relying on their clinical trial services’ support network and expertise. | Corporate Officer/Principal | - | - |
Ausbildung von Anuj Aggarwal
Arizona State University | Undergraduate Degree |
Eller College of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 2 |
Comptroller/Controller/Auditor | 1 |
Director of Finance/CFO | 1 |
Sektoral
Consumer Services | 3 |
Electronic Technology | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EVERSPIN TECHNOLOGIES, INC. | Electronic Technology |
Private Unternehmen | 1 |
---|---|
Patheon Pharmaceuticals, Inc.
Patheon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Patheon, Inc., Patheon Pharmaceuticals, Inc. is a trusted end-to-end contract development and manufacturing organization partner for the pharmaceutical, biotech, and life sciences industries. The company is based in Durham, NC. Benefit from a single vendor along your entire development journey by relying on their clinical trial services’ support network and expertise. | Health Technology |
- Börse
- Insiders
- Anuj Aggarwal
- Erfahrung